Mammalian Transient Protein Expression Market Size & Share, by Product (Instruments, Expression Vector, Reagents & Consumables, Cell Lines); Application (Bio-production, Functional Cell-Based Assays, Academic Research); End-user (Contract Research Organizations, Biopharmaceutical Companies, Academic & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4560
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Companies Dominating the Mammalian Transient Protein Expression Landscape

    • Thermo Fisher Scientific Company

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Promega Corporation
    • Lonza Group
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN GmbH
    • Takara Bio India Pvt. Ltd.
    • HiMedia Laboratories Pvt Ltd
    • Sino Biological, Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Merck KgaA announced its expansion in October 2020, with the opening of a new membrane production plant in Darmstadt, Germany. The goal was to increase the production of Millipore Express membranes, which aid in the sterility of biological drug products.

  • Agilent Technologies, Inc. to become the partner with Akoya Biosciences, Inc. to develop multiplex-immunohistochemistry diagnostic solutions. This solution will be helpful for tissue analysis to commercialize this solution.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4560
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing health expenditure across the global population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2033.

Lack of expert healthcare professionals to handle the therapeutic protein generation are estimated to be the growth hindering factors for the market expansion.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Merck KGaA, Promega Corporation, Lonza Group, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH, Takara Bio India Pvt. Ltd., HiMedia Laboratories Pvt. Ltd, Sino Biological, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end-user, and by region.

The contract research organizations segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying